Messenger RNA of the Histidine-Rich Glycoprotein in Breast Tumors


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The content of mRNA of the histidine-rich glycoprotein (HRG), a potential marker of malignant neoplasia, which can be used in differential diagnosis of breast tumors, was determined in 110 breast tumor biopsy samples. The presence of HRG mRNA did not depend on the cancer type, on the preoperative treatment or its absence, as well as on the tumor progression stage and the presence of metastases.

Sobre autores

A. Autenshlyus

Ministry of Healthcare of the Russian Federation; Research Institute of Molecular Biology and Biophysics

Autor responsável pela correspondência
Email: lpciip@211.ru
Rússia, Novosibirsk, 630091; Novosibirsk, 630117

I. Brusentsov

Ministry of Healthcare of the Russian Federation; Federal Research Center Institute of Cytology and Genetics, Siberian Branch

Email: lpciip@211.ru
Rússia, Novosibirsk, 630091; Novosibirsk, 630090

I. Marinkin

Ministry of Healthcare of the Russian Federation

Email: lpciip@211.ru
Rússia, Novosibirsk, 630091

S. Smirnova

JSC Vector-Best

Email: lpciip@211.ru
Rússia, Kol’tsovo, Novosibirsk oblast, 633159

M. Rukavishnikov

JSC Vector-Best

Email: lpciip@211.ru
Rússia, Kol’tsovo, Novosibirsk oblast, 633159

V. Lyakhovich

Research Institute of Molecular Biology and Biophysics

Email: lpciip@211.ru
Rússia, Novosibirsk, 630117

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018